Association between maternal anti-Ro and anti-La antibody levels and congenital heart block: a 20-year cohort study
Archives of Gynecology and Obstetrics · 21.02.2026 · 313 (1)
DOI: 10.1007/s00404-026-08360-z ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 21.02.2026. Verfasst von Gabriel Duque Pannain und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Fetal Medicine, Department of Obstetrics, School of Medicine, University of São Paulo (FMUSP), São Paulo, São Paulo, Brazil. gabrielduque…. Hauptthemen laut MEDLINE: Heart Block, Antibodies, Antinuclear. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the association between maternal anti-Ro and anti-La antibody levels and the occurrence of congenital heart block (CHB) in fetuses and newborns.
Methods
This retrospective cohort study included 182 pregnant women with positive anti-Ro and/or anti-La antibodies who received prenatal care at our tertiary center between 2002 and 2022. Maternal clinical, laboratory, and obstetric variables were analyzed.
Results
Thirteen fetuses (7.1%) were diagnosed with CHB. Mothers of affected fetuses had significantly higher anti-Ro (median 240 vs. 42; p < 0.001) and anti-La (median 150 vs. 10; p < 0.001) levels. Anti-La positivity was more frequent in the CHB group (76.9% vs. 42.6%; p = 0.017). Lower complement C4 levels ( p = 0.008) and disease duration of less than 1 year since diagnosis ( p = 0.008) were also associated with CHB. Preconception hydroxychloroquine and prednisone use were less frequent in affected pregnancies ( p = 0.044 and p = 0.039, respectively).
Conclusion
Higher maternal anti-Ro and anti-La antibody levels were significantly associated with fetal CHB. Preconception hydroxychloroquine may provide a protective effect. Early diagnosis and specialized care are essential for optimizing neonatal outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Fetal Medicine, Department of Obstetrics, School of Medicine, University of São Paulo (FMUSP), São Paulo, São Paulo, Brazil. gabrielduquep@gmail.com.
- Division of Fetal Medicine, Department of Obstetrics, School of Medicine, University of São Paulo (FMUSP), São Paulo, São Paulo, Brazil.
- Division of Neonatology, Department of Pediatrics, School of Medicine, University of São Paulo (FMUSP), São Paulo, São Paulo, Brazil.
Zitieren
APA
Pannain, G. D., Andrade, J. Q., Lopes, M. A. B., Camargo, F. M., Krebs, V. L. J., de Carvalho, W. B., & Francisco, R. P. V. (2026). Association between maternal anti-Ro and anti-La antibody levels and congenital heart block: a 20-year cohort study. Archives of Gynecology and Obstetrics, 313(1). https://doi.org/10.1007/s00404-026-08360-z
Vancouver
Pannain GD, Andrade JQ, Lopes MAB, Camargo FM, Krebs VLJ, de Carvalho WB, et al. Association between maternal anti-Ro and anti-La antibody levels and congenital heart block: a 20-year cohort study. Archives of Gynecology and Obstetrics. 2026;313(1). doi:10.1007/s00404-026-08360-z
BibTeX
@article{Pannain2026,
author = {Pannain, Gabriel Duque and Andrade, Joelma Queiroz and Lopes, Marco Antônio Borges and Camargo, Fabrício Marcondes and Krebs, Vera Lúcia Jornada and de Carvalho, Werther Brunow and Francisco, Rossana Pulcinelli Vieira},
title = {Association between maternal anti-Ro and anti-La antibody levels and congenital heart block: a 20-year cohort study},
journal = {Archives of Gynecology and Obstetrics},
year = {2026},
volume = {313},
number = {1},
doi = {10.1007/s00404-026-08360-z}
}
EUVIMED